Moderna, Inc.
MRNA
$36.12
$0.511.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.12B | 13.00M | -1.28B | -1.18B | 217.00M |
| Total Depreciation and Amortization | 60.00M | 52.00M | 41.00M | 36.00M | 202.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 148.00M | 98.00M | 110.00M | 90.00M | -874.00M |
| Change in Net Operating Assets | 1.74B | -1.73B | -146.00M | 60.00M | 1.08B |
| Cash from Operations | 825.00M | -1.57B | -1.27B | -989.00M | 622.00M |
| Capital Expenditure | -522.00M | -151.00M | -182.00M | -196.00M | -220.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.00M | 872.00M | 1.83B | 314.00M | -318.00M |
| Cash from Investing | -539.00M | 721.00M | 1.65B | 118.00M | -538.00M |
| Total Debt Issued | -4.00M | 3.00M | 1.00M | -- | -- |
| Total Debt Repaid | -10.00M | -- | 1.00M | -1.00M | -124.00M |
| Issuance of Common Stock | 11.00M | 8.00M | 32.00M | 15.00M | 15.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.00M | 11.00M | 34.00M | 14.00M | -109.00M |
| Foreign Exchange rate Adjustments | -1.00M | 1.00M | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 282.00M | -833.00M | 409.00M | -857.00M | -25.00M |
